United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2004_register
executive
2010-09-23
article
Schedules of Controlled Substances: Placement of Alpha-Methyltryptamine and 5-Methoxy-N,N-Diisopropyltryptamine Into Schedule I of the Controlled Substances Act
Rules and Regulations
D09002ee1bde70de4
D09002ee1bde70f52
United States
Department of Justice
originator
org
United States Government Agency or Subagency
United States
Drug Enforcement Administration
originator
org
United States Government Agency or Subagency
This final rulemaking is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place alpha- methyltryptamine (AMT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO- DIPT) into Schedule I of the Controlled Substances Act (CSA). This action by the DEA Deputy Administrator is based on a scheduling recommendation by the Department of Health and Human Services (DHHS) and a DEA review indicating that AMT and 5-MeO-DIPT meet the criteria for placement in Schedule I of the CSA. This final rule will continue to impose the regulatory controls and criminal sanctions of Schedule I substances on the manufacture, distribution, and possession of AMT and 5-MeO-DIPT.
69 FR 58050
https://www.govinfo.gov/app/details/FR-2004-09-29/04-21755
04-21755
fr29se04-8
4410-09-P
Docket No. DEA-252F
https://www.govinfo.gov/app/details/FR-2004-09-29/04-21755
https://www.govinfo.gov/content/pkg/FR-2004-09-29/html/04-21755.htm
https://www.govinfo.gov/content/pkg/FR-2004-09-29/pdf/04-21755.pdf
Administrative Practice and Procedure
Drug Traffic Control
Reporting and Recordkeeping Requirements
4 p.
58050
58053
69 FR 58050
Code of Federal Regulations
Title 21 Part 1308
21 CFR Part 1308
Schedules of Controlled Substances: Placement of Alpha-Methyltryptamine and 5-Methoxy-N,N-Diisopropyltryptamine Into Schedule I of the Controlled Substances Act; Federal Register Vol. 69, Issue
RULE
04-21755
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Docket No. DEA-252F
4410-09-P
04-21755
Final rule.
This final rulemaking is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place alpha- methyltryptamine (AMT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO- DIPT) into Schedule I of the Controlled Substances Act (CSA). This action by the DEA Deputy Administrator is based on a scheduling recommendation by the Department of Health and Human Services (DHHS) and a DEA review indicating that AMT and 5-MeO-DIPT meet the criteria for placement in Schedule I of the CSA. This final rule will continue to impose the regulatory controls and criminal sanctions of Schedule I substances on the manufacture, distribution, and possession of AMT and 5-MeO-DIPT.
September 29, 2004.
Christine Sannerud, PhD, Chief, Drug and Chemical Evaluation Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537, Telephone (202) 307- 7183.
Administrative Practice and Procedure
Drug Traffic Control
Reporting and Recordkeeping Requirements
Schedules of controlled substances:
Alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine; placement into Schedule I,
Federal Register
Vol. 69, no. 188
Office of the Federal Register, National Archives and Records Administration
2004-09-29
continuing
daily
deposited
born digital
226 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2004-09-29
P0b002ee180983700
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr29se04
https://www.govinfo.gov/app/details/FR-2004-09-29
https://www.govinfo.gov/content/pkg/FR-2004-09-29/pdf/FR-2004-09-29.pdf
https://www.govinfo.gov/content/pkg/FR-2004-09-29/xml/FR-2004-09-29.xml
fdlp
58035
58250
DGPO
2010-09-23
2023-05-03
FR-2004-09-29
machine generated
eng
FR
FR-2004-09-29
69
188